Action Sports Camera and Memory Device Sales
Quote | Innovate Biopharmaceuticals Inc. (NASDAQ:INNT)
Last: | $0.56 |
---|---|
Change Percent: | -20.23% |
Open: | $0.72 |
Close: | $0.56 |
High: | $0.72 |
Low: | $0.551 |
Volume: | 1,506,937 |
Last Trade Date Time: | 05/01/2020 04:46:58 am |
News | Innovate Biopharmaceuticals Inc. (NASDAQ:INNT)
Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC Lead program, a proprietary long-acting GLP-1 receptor agonist, starting Phase 2 trial for Short Bowel Syndrome (SBS), an underserved, orphan condition Continued Phase 3 trial of larazotide; first and on...
RALEIGH, NC / ACCESSWIRE / March 20, 2020 / Innovate Biopharmaceuticals, Inc. (the "Company" or "Innovate") (NASDAQ:INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced that it has filed its 2019 Annual Report on Form...
Message Board Posts | Innovate Biopharmaceuticals Inc. (NASDAQ:INNT)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Innovate Biopharmaceuticals Inc. Company Name:
INNT Stock Symbol:
NASDAQ Market:
Innovate Biopharmaceuticals Inc. Website:
Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC Lead program, a proprietary long-acting GLP-1 receptor agonist, starting Phase 2 trial for Short Bowel Syndrome (SBS), an underserved, orphan condition Continued Phase 3 trial of larazotide; first and on...
RALEIGH, NC / ACCESSWIRE / March 20, 2020 / Innovate Biopharmaceuticals, Inc. (the "Company" or "Innovate") (NASDAQ:INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced that it has filed its 2019 Annual Report on Form...
Israeli Regulatory Approvals Appear on Track for Late March 2020 to Allow Closing of the Merger RALEIGH, NC / ACCESSWIRE / March 11, 2020 / Innovate Biopharmaceuticals, Inc. (NASDAQ:INNT), a clinical-stage biotechnology company focused on developing novel therapeutics for autoimmune a...